(Q33922744)

30 July 2017

1 reference

title

Subcortical vascular dementia as a specific target for clinical trials (English)

1 reference

30 July 2017

1 reference

Inzitari D

1

1 reference

30 July 2017

Erkinjuntti T

2

1 reference

30 July 2017

Wallin A

3

1 reference

30 July 2017

Del Ser T

4

1 reference

30 July 2017

Romanelli M

5

1 reference

30 July 2017

Pantoni L

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Annals of the New York Academy of Sciences

30 July 2017

1 reference

30 July 2017

903

1 reference

30 July 2017

510-521

1 reference

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

30 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Senile dementia of the Binswanger type. A vascular form of dementia in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Binswanger's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Why do frontal lobe symptoms predominate in vascular dementia with lacunes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Formation of cerebrovascular anomalies in the ageing rat is delayed by chronic nimodipine application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Nimodipine effects on cerebral microvessels and sciatic nerve in aging rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Leukoaraiosis in relation to prognosis for patients with lacunar infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Dementia associated with lacunar infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

New clinical relevance of leukoaraiosis. European Task Force on Age-Related White Matter-Changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Overview of clinical trials of hydergine in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Propentofylline in the treatment of Alzheimer's disease and vascular dementia: a review of phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Frontal-subcortical circuits and human behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Pathogenesis of leukoaraiosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

Ischemic stroke and incomplete infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06407.X

10.1111/J.1749-6632.2000.TB06407.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference